Planta Med 2020; 86(01): 55-60
DOI: 10.1055/a-1021-0611
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Eglerisine, a Novel Sesquiterpenoid Tropolone from Dulacia egleri with Antiproliferative Effect against an Acute Myeloid Leukemia Lineage

Leice M. R. de Novais
1   Departamento de Química, Universidade Federal de Mato Grosso, Cuiabá, MT, Brazil
,
Luiz F. Ferreira
1   Departamento de Química, Universidade Federal de Mato Grosso, Cuiabá, MT, Brazil
,
Paulo T. de Sousa Jr.
1   Departamento de Química, Universidade Federal de Mato Grosso, Cuiabá, MT, Brazil
,
Tereza A. N. Ribeiro
1   Departamento de Química, Universidade Federal de Mato Grosso, Cuiabá, MT, Brazil
,
Marcos J. Jacinto
1   Departamento de Química, Universidade Federal de Mato Grosso, Cuiabá, MT, Brazil
,
Carlos H. C. dos Santos
2   Departamento de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica, RJ, Brazil
,
Mário G. de Carvalho
2   Departamento de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica, RJ, Brazil
,
Heron F. V. Torquato
3   Departamento de Bioquímica, Universidade Federal de São Paulo, São Paulo, SP, Brazil
4   Faculdade de Farmácia, Braz Cubas Educação, Mogi das Cruzes, SP, Brazil
,
Edgar J. Paredes-Gamero
3   Departamento de Bioquímica, Universidade Federal de São Paulo, São Paulo, SP, Brazil
5   Faculdade de Ciências Farmacêuticas, Alimentos e Nutrição (FACFAN), Universidade Federal de Mato Grosso do Sul, Campo Grande, MS, Brazil
,
Virgínia C. P. Silva
1   Departamento de Química, Universidade Federal de Mato Grosso, Cuiabá, MT, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 19. April 2019
revised 23. September 2019

accepted 30. September 2019

Publikationsdatum:
17. Oktober 2019 (online)

Preview

Abstract

Chemical investigation of the stems of Dulacia egleri resulted in the isolation of eglerisine (1), a compound with a rare sesquiterpenoid tropolone skeleton. Its structure was determined by analysis of spectrometric and spectroscopic data, including HRESIMS, 1D, and 2D NMR. The antiproliferative effects of eglerisine were tested in human leukemia lineages. In the Kasumi-1 lineage, an acute myeloid leukemia cell line, eglerisine reduced cell metabolism, as determined by the resazurin assay. Eglerisine did not induce cell death by either apoptotic or necrotic mechanisms. However, a reduction of the absolute number of cells was observed. Eglerisine induced cell cycle arrest after 72 h of treatment by phosphorylation of H2AX histone, reducing the S phase and increasing the G2 phase of the cell cycle.

Supporting Information